Wesley Clark - 01 Jun 2023 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Jason Liljestrom, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
01 Jun 2023
Net transactions value
+$20,370
Form type
4
Filing time
05 Jun 2023, 19:54:46 UTC
Previous filing
15 Jun 2022
Next filing
15 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBRX Common Stock Purchase $20,370 +7,000 +700% $2.91 8,000 01 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.